Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rekom Biotech is a private Spanish biotechnology company focused on the design and manufacture of in vitro diagnostic reagents for the diagnostics industry. The company supplies recombinant antigens, recombinant allergens, monoclonal and polyclonal antibodies, biotinylated and HRP-conjugated proteins, immunoassay blockers, and custom reagent development services. Its products are used across multiple diagnostic formats including ELISA, immunochromatography, chemiluminescence, western blot, and dot blot. Rekom Biotech emphasizes infectious disease and allergy diagnostics in both human and veterinary settings, with a particular specialty in multi-epitope chimeric recombinant proteins intended to improve assay sensitivity and specificity. The company operates under ISO 9001 and ISO 13485 quality systems and appears to be commercially active as a reagent supplier rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rekom Biotech.